| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:24837741 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:36450496; PMID:39826883 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:36450496 |
| GO:0006171 | Camp biosynthetic process | Affects phenotype | PMID:32115946 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:26238291 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:36450496; PMID:39826883 |
| GO:0006879 | Cellular iron ion homeostasis | Affects phenotype | PMID:39826883 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:28529061 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:37436145 |
| GO:0006974 | Cellular response to dna damage stimulus | Affects phenotype | PMID:24269554; PMID:28593498; PMID:34454013 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:36450496; PMID:39826883 |
| GO:0008219 | Cell death | Increases phenotype | PMID:28593498 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:34454013; PMID:39287666 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:30453383; PMID:34196753; PMID:35038060 |
| GO:0010587 | Mirna catabolic process | Increases phenotype | PMID:35038060 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:37579952 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:35940284 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:28077981 |
| GO:0014902 | Myotube differentiation | Decreases phenotype | PMID:24431215 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:39287666 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:36450496 |
| GO:0032205 | Negative regulation of telomere maintenance | Increases phenotype | PMID:37579952 |
| GO:0032310 | Prostaglandin secretion | Affects phenotype | PMID:32115946 |
| GO:0032981 | Mitochondrial respiratory chain complex i assembly | Decreases phenotype | PMID:37579952 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:39826883 |
| GO:0042770 | Signal transduction in response to dna damage | Increases phenotype | PMID:30453383 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:37579952 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:24837741; PMID:34454013; PMID:36450496; PMID:39826883 |
| GO:0044319 | Wound healing, spreading of cells | Decreases phenotype | PMID:28529061 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:28529061; PMID:35038060 |
| GO:0051402 | Neuron apoptotic process | Increases phenotype | PMID:32115946 |
| GO:0051490 | Negative regulation of filopodium assembly | Increases phenotype | PMID:30011042 |
| GO:0055072 | Iron ion homeostasis | Affects phenotype | PMID:36450496 |
| GO:0060326 | Cell chemotaxis | Increases phenotype | PMID:34610339; PMID:39287666 |
| GO:0070265 | Necrotic cell death | Affects phenotype | PMID:24837741 |
| GO:0070987 | Error-free translesion synthesis | Increases phenotype | PMID:28077981 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:36450496 |
| GO:0090298 | Negative regulation of mitochondrial dna replication | Increases phenotype | PMID:37579952 |
| GO:0097707 | Ferroptosis | Increases phenotype | PMID:36450496 |
| GO:0140639 | Positive regulation of pyroptosis | Increases phenotype | PMID:35297523 |
| GO:0140742 | Lncrna transcription | Increases phenotype | PMID:35038060 |
| GO:1901164 | Negative regulation of trophoblast cell migration | Increases phenotype | PMID:30011042 |
| GO:1901987 | Regulation of cell cycle phase transition | Affects phenotype | PMID:37579952 |
| GO:1902808 | Positive regulation of cell cycle g1/s phase transition | Increases phenotype | PMID:37579952 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:28529061 |
| GO:2000774 | Positive regulation of cellular senescence | Increases phenotype | PMID:37579952 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.